Association of Sacubitril/Valsartan with Metabolic Parameters in Patients with Reduced Ejection Fraction Heart Failure at a Multidisciplinary Clinic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of Sacubitril/Valsartan with Metabolic Parameters in Patients with Reduced Ejection Fraction Heart Failure at a Multidisciplinary Clinic

Published:2021-03-01 Issue:2 Volume:19 Page:115-118
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Ryu Rachel¹,Tran Huyentran²,Bahjri Khaled³

Affiliation:

1. Department of Pharmacy Practice and Administration, Western University College of Pharmacy, Pomona, California, USA.

2. Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, California, USA.

3. Department of Pharmaceutical and Administrative Sciences, Loma Linda University School of Pharmacy, Loma Linda, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/met.2020.0100

Reference21 articles.

1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

2. Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial

3. Potential Expanded Indications for Neprilysin Inhibitors

4. Neprilysin inhibitors: A new hope to halt the diabetic cardiovascular and renal complications?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure therapy challenges in obese patients;Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma;2023

2. Effects of Sacubitril/Valsartan on Glycemic Control in Japanese Patients With Heart Failure and/or Hypertension;Circulation Reports;2022-12-09

3. Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction;Clinical Drug Investigation;2022-05-30

4. The Obesity Paradox in Heart Failure: Is It Still Valid in Light of New Therapies?;Cardiology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3